Kailera Therapeutics, Inc.
USD22.59
-0.59 (-2.55%)
CEO
Ronald C. Renaud Jr.
IPO Date
2026-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.20
Prev. Close
$23.18
Day Low
$22.30
Day High
$23.84
52W Low
$19.01
52W High
$28.23
Market Cap
$2.93B
Volume
0.44M
| 500,000 |
| $16.00 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | C-Conversion | Disposed | 8,250,000 | $0.00 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | C-Conversion | Disposed | 2,026,820 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Acquired | 9,477,719 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Acquired | 2,034,133 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Disposed | 4,968,789 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Disposed | 708,814 | $0.00 |
| 20 Apr 2026 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | C-Conversion | Acquired | 17,857,143 | $0.00 |
| 20 Apr 2026 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | P-Purchase | Acquired | 8,398,438 | $16.00 |